| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f6e4b9d70b1d5bc7e837dc9b98fcac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1636e84fffafc3b73b79b92758ec724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aefc0a075c9a9f84abb011bf42071d46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7199f5d2b3e20cace70c496143ab9336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f4a3577832ccd68c9641005b1f37092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07a757c0283dbccd66b69e4328299ad8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 |
| filingDate |
2007-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dd5f9b35290027ab239e885d8808cda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59e5a07165ae35e5d6055ac34f00b7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7849b7c8bb5c7320701fb8fa63cbde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c83020138d3552f91135db56a9daa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1919bb9c115a8c6a58875269a2dc7de7 |
| publicationDate |
2008-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008085406-A2 |
| titleOfInvention |
Modified live (jmso strain) haemophilus parasuis vaccine |
| abstract |
The present invention is a culture of cells of Haemophilus parasuis exhibiting attenuated pathogenicity and capable of triggering a protective immune response when administered to pigs as a live vaccine. The present invention is also a method of preparing the cell culture, a method of preparing a vaccine from the cell culture, and a live vaccine based on the cell culture. The cell culture was modified from a pathogenic parent strain by MNNG mutagenesis and was selected by complete dependence on streptomycin for growth. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012225091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102559531-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011131789-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9132183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10004740-B2 |
| priorityDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |